SARS News and Research

RSS

New surgical mask with an intelligent fabric can instantaneously deactivate SARS-COV-2 virus

The intelligent fabric of these masks has been created by a team of researchers from the San Alberto Magno Traslational Centre (CITSAM-UCV), led by professor Ángel Serrano.

20 Sep 2021

COVID-19 vaccine-related allergies are rare, typically mild and treatable, finds study

Allergic reactions to the new mRNA-based COVID-19 vaccines are rare, typically mild and treatable, and they should not deter people from becoming vaccinated, according to research from the Stanford University School of Medicine.

20 Sep 2021

Research on SARS-CoV-2 and dendritic cells may explain why virus is so virulent

In a recent study released on the bioRxiv* preprint server, the researchers suggest that an aberrant inflammatory reaction associated with COVID-19 could be a result of escape from direct sensing by toll-like receptors (TLRs). Moreover, the researchers indicate that this phenomenon might underlie the lack of efficient immunity to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) early during infection.

20 Sep 2021

Study highlights the usefulness of organoids for basic research into coronaviruses

Researchers from the group of Hans Clevers in collaboration with the group of Bart Haagmans (Erasmus MC) established an organoid biobank to search for the genes that are essential for the spreading of a SARS-CoV2 infection.

20 Sep 2021

Myocarditis risk from mRNA COVID vaccines re-evaluated in Canadian study (Research Now Withdrawn)

Scientists from the University of Ottawa, Canada, have recently estimated the prevalence of myocarditis/pericarditis in individuals recently immunized with mRNA-based coronavirus disease 2019 (COVID-19) vaccines. The analysis reveals a prevalence of 10 myopericarditis cases for every 10,000 vaccine doses. The study is currently available on the medRxiv* preprint server.

20 Sep 2021

New QCovid tool helps identify vaccinated groups at highest risk of Covid-19 hospitalization and death

Researchers from the University of Oxford have today reported on findings on the vaccinated people who are at greatest risk from severe Covid-19 leading to hospitalization or death from 14 days post the second dose vaccination, when substantial immunity should be expected.

20 Sep 2021

The influence of prior seasonal coronavirus infection on disease severity in COVID-19

A new study posted to the bioRxiv* server attempted to explore anti-spike IgG responses, Fc-gamma receptor (FcγR) activation, IgG targeting of immunodominant regions, and recall responses due to seasonal hCoV infections in non-hospitalized COVID-19 patients.

20 Sep 2021

Characterizing the flexibility of SARS-CoV-2 variant of concern spike proteins

A novel protein modeling method assesses changes to the conformation of the SARS-CoV-2 spike protein that have been encountered by mutation.

19 Sep 2021

Development of a potential pan-variant aerosol to manage COVID-19

Researchers hypothesized that if APN01 could be directly introduced into the airways of an infected person, it could locally neutralize SARS-CoV-2.

19 Sep 2021

A new synthetic multiantigen MVA vaccine COH04S1 effective against SARS-CoV-2

A new study utilized MVA to develop vaccine candidates that were subsequently evaluated in animal models of congenital cytomegalovirus disease.

19 Sep 2021

Combining antibody markers to improve serosurveillance for SARS-CoV-2

The current study found that combining N antibodies with nucleocapsid-specific IgG facilitates a better classification of SARS-CoV-2 infection.

19 Sep 2021

A variant analysis approach for SARS-CoV-2 in wastewater samples

A recent study proposes a simple and specific method for the enhanced detection of the SARS-CoV-2 VOCs in wastewater samples.

19 Sep 2021

Researcher explores the genetic interplay between personality traits and COVID

In a recent study, scientists aimed to find the genetic effects that the coronavirus disease 2019 (COVID-19) has on individuals with psychiatric disorders.

19 Sep 2021

Researchers report on under-sequenced region of S gene of the SARS-CoV2 Delta variant

In a recent study, Swiss researchers use improved techniques to understand the biological significance behind the Delta variant.

19 Sep 2021

Study shows efficacy of mRNA vaccines against SARS-CoV-2 in individuals with obesity

A new study evaluated the antibody response against SARS-CoV-2 between individuals who were affected by abdominal obesity (AO) and those who were not,

19 Sep 2021

Third dose of Pfizer-BioNTech vaccine increases neutralizing antibody levels against SARS-CoV-2

A third dose of the Pfizer-BioNTech vaccine significantly increased neutralizing antibody levels against SARS-CoV-2, the virus that causes COVID-19, according to new research published in the New England Journal of Medicine.

18 Sep 2021

A 100% French nasal vaccine against SARS-CoV-2 to move into the clinical phase in 2022

In contrast to intramuscular vaccines, only nasal vaccines are able to block the virus in the nose by inducing local immunity in the nasal mucosa, i.e. the portal of entry and multiplication of the virus.

18 Sep 2021

UW Medicine enrolls volunteers for COVID-19 booster vaccine trial

Researchers at the University of Washington School of Medicine are enrolling volunteers for a COVID-19 booster vaccine trial.

18 Sep 2021

Thousands of vulnerable hospital patients set to benefit from new COVID-19 treatment

Thousands of vulnerable NHS patients in hospital due to COVID-19 are set to benefit from a ground-breaking new antibody treatment, the government has announced today (17 September 2021).

18 Sep 2021

What pushed Israel out of herd immunity?

Scientists have recently tried to explain the factors that could be responsible for the recent outbreaks of COVID-19 in Israel.

17 Sep 2021

SARS News and Research

New surgical mask with an intelligent fabric can instantaneously deactivate SARS-COV-2 virus

COVID-19 vaccine-related allergies are rare, typically mild and treatable, finds study

Research on SARS-CoV-2 and dendritic cells may explain why virus is so virulent

Study highlights the usefulness of organoids for basic research into coronaviruses

Myocarditis risk from mRNA COVID vaccines re-evaluated in Canadian study (Research Now Withdrawn)

New QCovid tool helps identify vaccinated groups at highest risk of Covid-19 hospitalization and death

The influence of prior seasonal coronavirus infection on disease severity in COVID-19

Characterizing the flexibility of SARS-CoV-2 variant of concern spike proteins

Development of a potential pan-variant aerosol to manage COVID-19

A new synthetic multiantigen MVA vaccine COH04S1 effective against SARS-CoV-2

Combining antibody markers to improve serosurveillance for SARS-CoV-2

A variant analysis approach for SARS-CoV-2 in wastewater samples

Researcher explores the genetic interplay between personality traits and COVID

Researchers report on under-sequenced region of S gene of the SARS-CoV2 Delta variant

Study shows efficacy of mRNA vaccines against SARS-CoV-2 in individuals with obesity

Third dose of Pfizer-BioNTech vaccine increases neutralizing antibody levels against SARS-CoV-2

A 100% French nasal vaccine against SARS-CoV-2 to move into the clinical phase in 2022

UW Medicine enrolls volunteers for COVID-19 booster vaccine trial

Thousands of vulnerable hospital patients set to benefit from new COVID-19 treatment

What pushed Israel out of herd immunity?

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News